|Filed Under:||Business & Finance / Investing|
|Posts on Regator:||10941|
|Posts / Week:||33|
|Archived Since:||February 17, 2011|
PNC, Wells Fargo, and M&T Bank reported the best DFAST results according to one analyst. What to expect when the Fed releases CCAR results next week.
The iShares U.S. Home Construction ETF and the SPDR S&P Homebuilders ETF are not the same.
Fans of renewable energy abound, including none other than President Trump.
Small-cap gold miners-tracking exchange-traded funds are gaining big.
Natural gas prices look attractive at $2.90/mmbtu, says one RBC Capital Markets analyst.
The Guggenheim Solar ETF hit a fresh seven-month high, clearing its 200-day moving average.
The CBOE Volatility Index is not a fortune-teller.
Falling cocoa prices may be "anchoring" bond yields and the U.S. dollar, according to Societe Generale.
Energy stocks got hit. Oil equipment and services companies bore the brunt of it.
The SPDR S&P Biotech ETF was among the best-performing on Wednesday.
One technical analyst says iShares Nadsdaq Biotechnology looks stronger than it did in prior breakouts.
This closed-end fund looks like a pretty good substitute for the 'world's most expensive ETF.'
One investment bank just downgraded 51 energy-related companies on a lower long-term crude oil forecast.
Deutsche Bank's equity strategist expects Europe stocks to lag behind U.S. stocks.
Volatility is back, but it's not showing much.
European bank stocks were burned following the first round of Brexit negotiations.
The biotechnology-stock rally continues. The SPDR S&P Biotech (XBI) and the iShares Nasdaq Biotechnology (IBB), among the highest-flying exchange-traded funds yesterday, both hit their 52-week highs on Tuesday. Photo by Peter Macdiarmid/Getty Images The SPDR S&P has gained 2.7% while the iShares Nasdaq has climbed 2.3% so far. Show More Summary
Crude oil prices are off more than 20% from its February peak.
The two largest technology-stock tracking ETFs are being treated very differently. And why one technical strategist says investors should wait before putting more money in tech.
ETFs could see increasing adoption from insurance companies.